Record Participation At ATTD In 2012
The Advanced Technologies and Treatments for Diabetes Conference counted this year a record number of attendees
Online, February 21, 2012 (Newswire.com) - Barcelona, Spain - The Advanced Technologies and Treatments for Diabetes Conference, which was held earlier this month in Barcelona counted this year a record number of attendees. Launched in 2008 with over 700 participants, in its fifth year almost 1700 experts visited the conference.
Professionals and experts from Europe (56%), North America (13%) and other parts of the world took part and contributed to 22 sessions on a variety of crucial topics related to treatment and prevention of diabetes and other causes that can lead to this malicious disease.
ATTD was attended by key industry leaders from the field of endocrinology, biotechnology, pediatrics and others. It was sponsored by internationally renowned medical enterprises such as Roche, Medtronic, Animas (Johnson & Johnson) and others.
Considered by the UN as an "Non-communicable Disease", diabetes has become an epidemic, with a person succumbing every 10 seconds. According to the World Diabetes Foundation, 285 million people worldwide suffer from diabetes and by 2025, 380 million people worldwide will have diabetes. Treating this malicious disease remains a highly challenging process due to the lack of proper technology and devices that are required for daily diabetes management.
About ATTD:
Launched in 2008 in Prague, Czech Republic, ATTD is an innovative diabetes technologies and treatments conference for researchers, clinicians and general practitioners in all fields of diabetes, endocrinology and metabolism and is yearly sponsored by key medical leaders. With over 1,500 participants and first class key note speakers in the field, the conference is considered the go-to networking event for researchers, clinicians and general practitioners in all fields of diabetes, endocrinology and metabolism. For the first time in 2012 the conference featured new and innovative technologies and medical devices for diabetes treatment by start-ups and new emerging companies.
For more information please contact:
Viktoria Kanar
Bottom Line Consulting for ATTD
(t) +972 54 3083731
vika@bottoml.com